Jili Cao
Zhejiang Key Laboratory Of Disease Syndrome Integration For Cancer Prevention And Treatment
Hangzhou, 310012, China
Hangzhou, 310012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Calcium channels as pharmacological targets for cancer therapy.
Journal: Clinical and experimental medicine
Published: January 08, 2025
Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 20, 2024
The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer.
Journal: Scientific reports
Published: August 12, 2024
Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 26, 2024
Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPARα-RXRα to down-regulate fatty acid metabolism.
Journal: Toxicology and applied pharmacology
Published: March 12, 2024
LncRNA CYP4A22-AS1 promotes the progression of lung adenocarcinoma through the miR-205-5p/EREG and miR-34c-5p/BCL-2 axes.
Journal: Cancer cell international
Published: March 17, 2023
Mechanistic insights on cytotoxicity of KOLR, Cinnamomum pauciflorum Nees leaf derived active ingredient, by targeting signaling complexes of phosphodiesterase 3B and rap guanine nucleotide exchange factor 3.
Journal: Phytotherapy research : PTR
Published: January 08, 2022
Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Journal: Oncotarget
Published: September 27, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026